Tag Archives: DRRX

Hot Medical Stocks To Buy Right Now

Big changes are under way right now in our neighbor to the north. Beginning Oct. 17, recreational marijuana will officially go on sale in Canada, making it the first industrialized country in the world to give adult-use weed the green light.

The legalization of marijuana in Canada is expected to generate up to $5 billion in annual sales once the industry is fully up to speed. Though some of this revenue will come from domestic markets, Canadian growers are angling to reap significant rewards from exports since roughly 30 countries having legalized medical cannabis to some degree. However, the United States won’t be one of those countries.

Image source: Getty Images.

The U.S. federal government stymies cannabis progress

Whereas most of the developed world appears to be progressing on their view of cannabis, the U.S. has remained stuck in neutral. Even though Oklahoma recently became the 30th state to have legalized medical marijuana in some capacity, the federal government has held firm on its stance that cannabis is a Schedule I substance. According to the Controlled Substances Act, that means marijuana is entirely illegal, prone to abuse, and devoid of any recognized medical benefits.

Hot Medical Stocks To Buy Right Now: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX) provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

  • [By Stephan Byrd]

    Credit Suisse Group set a $525.00 price objective on Equinix (NASDAQ:EQIX) in a research report report published on Friday. The firm currently has a buy rating on the financial services provider’s stock.

  • [By Beth McKenna]

    Equinix (NASDAQ:EQIX) reported robust first-quarter 2018 financial results after the market close on Wednesday. 

    Shares closed down 6.1% on Thursday, which we can probably attribute to the company revising slightly downward its full-year 2018 adjusted funds from operations (AFFO) outlook, as we’ll get to in a moment. (AFFO is a closely watched metric for companies organized as real estate investment trusts, or REITs. It’s akin to “earnings” for REITs.) 

Hot Medical Stocks To Buy Right Now: Harte-Hanks, Inc.(HHS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Bioblast Pharma Ltd. (NASDAQ: ORPN) shares rose 29.6 percent to $3.22.
    Mannatech, Incorporated (NASDAQ: MTEX) surged 23.3 percent to $19.60 after the company reported commencement of modified Dutch auction cash tender for up to $16 million of common stock.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.1 percent to $15.8003.
    Quotient Limited (NASDAQ: QTNT) gained 18.1 percent to $5.54 following commencement of EU blood grouping field trial.
    Shineco, Inc. (NASDAQ: TYHT) climbed 17.1 percent to $1.9899 following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    CPI Card Group Inc. (NASDAQ: PMTS) rose 17 percent to $3.0999.
    Dover Downs Gaming & Entertainment, Inc. (NYSE: DDE) shares climbed 12 percent to $2.2613. The stock spiked more than 14 percent Thursday near the close as traders circulate word the Delaware lottery is planning to introduce full sports betting in June.
    Harte Hanks, Inc. (NYSE: HHS) shares gained 7.2 percent to $11.05 after the company late Thursday appointed four new independent directors to board.
    Cronos Group Inc. (NASDAQ: CRON) rose 6.4 percent to $6.17.
    VivoPower International PLC (NASDAQ: VVPR) shares gained 6.3 percent to $3.74.
    Global Self Storage, Inc. (NASDAQ: SELF) shares climbed 6 percent to $4.20.

    Check out these big penny stock gainers and losers

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Harte Hanks (NYSE:HHS) from a sell rating to a hold rating in a research report sent to investors on Monday.

    HHS has been the topic of a number of other reports. Noble Financial reaffirmed a buy rating on shares of Harte Hanks in a research note on Monday, March 5th. Zacks Investment Research raised shares of Harte Hanks from a hold rating to a strong-buy rating and set a $12.00 target price on the stock in a research note on Tuesday, May 15th.

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern’s rankings:

    Get Harte Hanks alerts:

    Harte-Hanks (HHS) Name Four New Independent Directors (streetinsider.com) Harte Hanks (HHS) Given $15.00 Consensus Price Target by Brokerages (americanbankingnews.com) Harte Hanks to Appoint Four New Independent Directors to the Board (feeds.benzinga.com) Harte Hanks (HHS) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com) Harte Hanks (HHS) Shares March Higher, Can It Continue? (zacks.com)

    Shares of Harte Hanks traded up $0.65, reaching $10.96, during trading hours on Friday, according to Marketbeat.com. The stock had a trading volume of 46,930 shares, compared to its average volume of 18,474. Harte Hanks has a 12 month low of $7.30 and a 12 month high of $14.40. The stock has a market capitalization of $64.54 million, a price-to-earnings ratio of -9.13 and a beta of 0.90.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Harte Hanks (NYSE:HHS) from a strong sell rating to a sell rating in a research report report published on Friday morning.

  • [By Logan Wallace]

    Noble Financial reissued their buy rating on shares of Harte Hanks (NYSE:HHS) in a report issued on Thursday.

    HHS has been the topic of a number of other research reports. ValuEngine upgraded shares of Harte Hanks from a strong sell rating to a sell rating in a report on Tuesday, August 28th. Zacks Investment Research cut shares of Harte Hanks from a hold rating to a strong sell rating in a report on Tuesday, August 14th.

Hot Medical Stocks To Buy Right Now: Durect Corporation(DRRX)

Advisors’ Opinion:

  • [By Brian Orelli]

    DURECT Corp. (NASDAQ:DRRX) is down 9.2% at 12:45 p.m. EDT after the U.S. Food and Drug Administration’s advisory committee voted 14 to 3 recommending the agency not approve Remoxy ER, an abuse-deterrent extended-release pain medication being developed by its partner Pain Therapeutics (NASDAQ: PTIE).

  • [By Shane Hupp]

    Headlines about DURECT (NASDAQ:DRRX) have been trending somewhat positive on Friday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. DURECT earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned news headlines about the specialty pharmaceutical company an impact score of 47.6857828380145 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on DURECT (DRRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on DURECT (DRRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Buy Right Now: American Airlines Group, Inc.(AAL)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was American Airlines Group Inc. (NASDAQ: AAL) which fell about 8% to $36.00. The stock’s 52-week range is $35.90 to $59.08. Volume was 24 million compared to the daily average volume of 6.2 million.

  • [By Chris Dier-Scalise]

    More evidence of strength in the contractors can be seen in a uptick in both government and private contracts. Boeing might be winner of the most high-profile and sizable agreements, recently winning both a $3.9 billion contract to modernize the Air Force One fleet as well as a deal with American Airlines Group Inc (NYSE: AAL) for 47 planes valued at $12 billion.

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Before the markets open, Bristol-Myers Squibb Company (NYSE: BMY) is projected to report quarterly earnings at $0.85 per share on revenue of $5.24 billion. Bristol-Myers shares rose 0.95 percent to $52.25 in after-hours trading.
    AT&T Inc. (NYSE: T) reported weaker-than-expected earnings

  • [By Adam Levine-Weinberg]

    Not surprisingly, the airlines with the lowest profit margins have been hit hardest. These carriers are the most vulnerable to fuel price increases and demand shocks, as small changes in their profit margins can severely impact their earnings. During the past year, American Airlines (NASDAQ:AAL) has fallen into the bottom echelon of U.S. airlines in terms of profitability, and so its share price tumbled 7.5% in the first three days of this week.

Hot Medical Stocks To Buy Right Now: Hibbett Sports Inc.(HIBB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Trexquant Investment LP acquired a new stake in shares of Hibbett Sports (NASDAQ:HIBB) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 12,159 shares of the company’s stock, valued at approximately $291,000.

  • [By Shane Hupp]

    Canaccord Genuity downgraded shares of Hibbett Sports (NASDAQ:HIBB) from a buy rating to a hold rating in a research report released on Monday, MarketBeat.com reports. The firm currently has $21.00 target price on the stock, down from their prior target price of $31.00.

  • [By Dan Caplinger]

    Wall Street had a major celebration on Friday, as the S&P 500 finished at an all-time high for the first time in roughly seven months. Investors generally pointed to Federal Reserve Chairman Jerome Powell’s comments that suggested that a gradual pace of future interest rate increases was the most likely scenario for the U.S. credit markets. The prospects for predictable monetary policy moves was a positive for the market overall, but there were still some companies that dealt with specific bad news that hurt their individual stock prices. Foot Locker (NYSE:FL), Hibbett Sports (NASDAQ:HIBB), and Grupo Supervielle (NYSE:SUPV) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Motley Fool Transcribers]

    Hibbett Sports Inc (NASDAQ:HIBB)Q2 2019 Earnings Conference CallAug. 24, 2018, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Hibbett Sports, Inc. (NASDAQ:HIBB) has received a consensus rating of “Hold” from the nineteen research firms that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and six have issued a buy rating on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $21.23.

  • [By Lisa Levin]

    Breaking news

    Foot Locker, Inc. (NYSE: FL) reported better-than-expected results for its first quarter.
    Hibbett Sports, Inc. (NASDAQ: HIBB) reported weaker-than-expected results for its first quarter.
    Ross Stores, Inc. (NASDAQ: ROST) reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter.
    Gap Inc (NYSE: GPS) posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter.

Top 5 High Tech Stocks To Buy Right Now

Cisco Systems, Inc. (NASDAQ:CSCO) – Stock analysts at Piper Jaffray Companies dropped their FY2019 earnings per share (EPS) estimates for shares of Cisco Systems in a research note issued on Monday, July 9th. Piper Jaffray Companies analyst A. Nowinski now expects that the network equipment provider will post earnings per share of $2.56 for the year, down from their previous forecast of $2.57. Piper Jaffray Companies currently has a “Buy” rating and a $50.00 price objective on the stock.

Get Cisco Systems alerts:

A number of other equities research analysts have also recently issued reports on the company. BidaskClub cut Cisco Systems from a “buy” rating to a “hold” rating in a report on Wednesday. JPMorgan Chase & Co. restated a “buy” rating on shares of Cisco Systems in a report on Monday, June 11th. Zacks Investment Research cut Cisco Systems from a “buy” rating to a “hold” rating in a report on Tuesday, May 22nd. Argus boosted their price objective on Cisco Systems to $55.00 and gave the stock a “buy” rating in a report on Friday, May 18th. Finally, Credit Suisse Group set a $41.00 price objective on Cisco Systems and gave the stock a “hold” rating in a report on Thursday, May 17th. Eleven equities research analysts have rated the stock with a hold rating, twenty-three have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $46.60.

Top 5 High Tech Stocks To Buy Right Now: Durect Corporation(DRRX)

Advisors’ Opinion:

  • [By Chris Lange]

    Durect Corp. (NASDAQ: DRRX) is also expecting a PDUFA date for its NDA of RBP-7000 in late July. The schizophrenia treatment has a target action date of July 28, 2018.

  • [By Stephan Byrd]

    Algert Global LLC lifted its stake in Durect Co. (NASDAQ:DRRX) by 338.9% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 498,711 shares of the specialty pharmaceutical company’s stock after acquiring an additional 385,088 shares during the quarter. Algert Global LLC’s holdings in Durect were worth $1,067,000 as of its most recent SEC filing.

  • [By Brian Orelli]

    DURECT Corp. (NASDAQ:DRRX) is down 9.2% at 12:45 p.m. EDT after the U.S. Food and Drug Administration’s advisory committee voted14 to 3 recommending the agency not approve Remoxy ER, an abuse-deterrent extended-release pain medication being developed by its partner Pain Therapeutics(NASDAQ: PTIE).

Top 5 High Tech Stocks To Buy Right Now: Biglari Holdings Inc.(BH)

Advisors’ Opinion:

  • [By Logan Wallace]

    Biglari Holdings (NYSE:BH)’s share price reached a new 52-week high and low during trading on Monday . The company traded as low as $195.09 and last traded at $197.24, with a volume of 16566 shares. The stock had previously closed at $209.09.

  • [By Lisa Levin]

    Shares of Biglari Holdings Inc. (NYSE: BH) were down 20 percent to $339.00. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Lisa Levin]

    Shares of Biglari Holdings Inc. (NYSE: BH) were down 17 percent to $352.05. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.

Top 5 High Tech Stocks To Buy Right Now: Alpine Total Dynamic Dividend Fund(AOD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Oppenheimer & Co. Inc. lifted its stake in shares of Alpine Total Dynamic Div (NYSE:AOD) by 14.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 101,451 shares of the investment management company’s stock after acquiring an additional 12,551 shares during the period. Oppenheimer & Co. Inc. owned 0.09% of Alpine Total Dynamic Div worth $906,000 as of its most recent SEC filing.

Top 5 High Tech Stocks To Buy Right Now: Oasis Petroleum Inc.(OAS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the media stories that may have impacted Accern Sentiment’s scoring:

    Get Oasis Petroleum alerts:

    Oasis Petroleum CEO: Oil prices always come back to suppl… (finance.yahoo.com) Oasis Petroleum (OAS) Price Target Raised to $17.00 at JPMorgan Chase (americanbankingnews.com) Oasis Petroleum (OAS) Rating Increased to Overweight at Morgan Stanley (americanbankingnews.com) Oasis Petroleum (OAS) Given Buy Rating at Williams Capital (americanbankingnews.com) Oasis Petroleum (OAS) Forecasted to Post FY2018 Earnings of $0.44 Per Share (americanbankingnews.com)

    Several equities research analysts have recently commented on the stock. Stephens set a $15.00 price target on shares of Oasis Petroleum and gave the stock a “buy” rating in a research report on Tuesday, April 24th. Williams Capital reiterated a “buy” rating and set a $18.00 price target on shares of Oasis Petroleum in a research report on Wednesday. JPMorgan Chase & Co. set a $17.00 price target on shares of Oasis Petroleum and gave the stock a “buy” rating in a research report on Wednesday. Morgan Stanley upgraded shares of Oasis Petroleum from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $12.52 to $19.00 in a research report on Wednesday. Finally, BMO Capital Markets lifted their price target on shares of Oasis Petroleum from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Tuesday, May 1st. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and sixteen have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $12.41.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Akorn, Inc. (NASDAQ: AKRX) fell 32.7 percent to $13.25 in pre-market trading after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 15.7 percent to $12.30 in pre-market trading. Subsea 7 confirmed a $7.00 per share proposal to acquire Mcdermott, pending termination of merger agreement with CB&I.
    Myomo, Inc. (NYSE: MYO) fell 9 percent to $3.65 in pre-market trading after rising 11.39 percent on Friday.
    Hasbro, Inc. (NASDAQ: HAS) fell 8 percent to $88.36 in pre-market trading after the company reported weaker-than-expected results for its first quarter on Monday.
    SunPower Corporation (NASDAQ: SPWR) fell 7.1 percent to $9.00 in pre-market trading.
    Endeavour Silver Corp. (NYSE: EXK) shares fell 5.9 percent to $2.88 in pre-market trading after declining 3.16 percent on Friday.
    Mattel, Inc. (NASDAQ: MAT) shares fell 5.5 percent to $12.25 in pre-market trading.
    Valeritas Holdings, Inc. (NASDAQ: VLRX) shares fell 5.1 percent to $2.96 in pre-market trading after rising 76.27 percent on Friday.
    GlobalSCAPE, Inc. (NYSE: GSB) fell 5.1 percent to $3.57 in pre-market trading.
    Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) shares fell 4.1 percent to $49.93 in pre-market trading.
    Oasis Petroleum Inc. (NYSE: OAS) fell 4.1 percent to $9.75 in pre-market trading. SunTrust Robinson Humphrey downgraded Oasis Petroleum from Hold to Sell

  • [By Matthew DiLallo]

    Earlier this year, I highlighted Oasis Midstream Partners (NYSE:OMP) as an intriguing company that income investors should put on their watchlist. On the plus side, theMLP offered an attractive and well-supported payout that it expected to grow at a high rate for the next few years. However, it was a riskier option since its sole source of income is oil-producing parent Oasis Petroleum(NYSE:OAS). Because of that, I thought the company needed to diversify a bit more to become an attractive option for income seekers.

  • [By Stephan Byrd]

    Element Capital Management LLC bought a new position in shares of Oasis Petroleum Inc. (NYSE:OAS) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 19,645 shares of the energy producer’s stock, valued at approximately $159,000.

Top 5 High Tech Stocks To Buy Right Now: China Petroleum & Chemical Corporation(SNP)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Sinopec (NYSE:SNP) have been trending somewhat positive on Saturday, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sinopec earned a coverage optimism score of 0.23 on Accern’s scale. Accern also gave headlines about the oil and gas company an impact score of 45.9265677546286 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    These are some of the news articles that may have effected Accern’s scoring:

    Get China Petroleum & Chemical alerts:

    China Petroleum & Chemical (SNP) and Statoil (STO) Critical Analysis (americanbankingnews.com) Sinopec to Import Record Crude Volumes From United States (finance.yahoo.com) Read This Before Buying China Petroleum & Chemical Corporation (HKG:386) For Its Upcoming $0.4 Dividend (finance.yahoo.com) Chevron (CVX) vs. Sinopec (SNP) Financial Analysis (americanbankingnews.com) Sinopec (SNP) Plans $4.57 Semi-Annual Dividend (americanbankingnews.com)

    China Petroleum & Chemical traded down $5.56, hitting $94.22, during trading on Thursday, MarketBeat Ratings reports. The company had a trading volume of 254,400 shares, compared to its average volume of 190,689. The stock has a market capitalization of $125.83 billion, a PE ratio of 16.92, a price-to-earnings-growth ratio of 1.83 and a beta of 1.29. China Petroleum & Chemical has a 1-year low of $69.60 and a 1-year high of $105.61. The company has a quick ratio of 0.62, a current ratio of 0.98 and a debt-to-equity ratio of 0.12.

  • [By Joseph Griffin]

    Sinopec (NYSE:SNP) announced a Semi-Annual dividend on Wednesday, March 28th, Zacks reports. Investors of record on Friday, May 25th will be paid a dividend of 4.568 per share by the oil and gas company on Thursday, June 21st. The ex-dividend date is Thursday, May 24th.

Top Undervalued Stocks For 2018

Related UPS Total Eclipse Of The Trucking Industry: Cosmic Event Sheds Light On How Key Component Of Supply Chain Is Changing Benzinga's Top Upgrades, Downgrades For August 8, 2017 UPS Vice President Of Global Health And Safety Alexi Carli Awarded High Honor By The National … (GuruFocus)
Related UAL Benzinga's Top Upgrades, Downgrades For September 20, 2017 Ray Dalio's Principles & Top 7 Most Undervalued Stocks Weekly Top Insider Buys Highlight for the Week of Sept. (GuruFocus)

On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about unusually high options activity in United Parcel Service, Inc. (NYSE: UPS). He said that options traders are buying the January 2020, 140 strike calls. Around 20,000 call options were traded in the first half of the session and traders were paying $3.20 for them. The trade breaks even at $143.20 or 21.12 percent above the current market price. Pete Najarian owns shares of UPS and he thinks the stock is going much higher.

Top Undervalued Stocks For 2018: First Harvest Corp., Prior to Reverse Merger with Cannavoices, Inc. (HVST)

Advisors’ Opinion:

  • [By Javier Hasse]

    First Harvest Corp (OTC: HVST), acquired Cannavoices, Inc., a developer of cannabis-focused mobile games and social media platforms.

    "A trend we've seen developing slowly but steadily [is one] wherenew channels are being developed to reach cannabis consumers, primarily due to limits in advertising. There is so much regulation in the space that, in such an entrepreneurial environment where there are really no incumbent leaders, people are trying to be creative and figuring out ways to reach the cannabis consumer, both as an undeserved demographic and, just one that has still got that taboo around it, [leading] to larger players not necessarily getting involved yet." "Basically, they are trying to figure out ways to reach the consumer without direct TV advertising and stuff like that.”

    Related Link: Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High

Top Undervalued Stocks For 2018: Durect Corporation(DRRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

  • [By Stephan Byrd]

    Algert Global LLC lifted its stake in Durect Co. (NASDAQ:DRRX) by 338.9% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 498,711 shares of the specialty pharmaceutical company’s stock after acquiring an additional 385,088 shares during the quarter. Algert Global LLC’s holdings in Durect were worth $1,067,000 as of its most recent SEC filing.

Top Undervalued Stocks For 2018: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).

Top Undervalued Stocks For 2018: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

Top Undervalued Stocks For 2018: ABAXIS Inc.(ABAX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Abaxis (NASDAQ:ABAX) have been assigned a consensus rating of “Hold” from the eleven research firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among analysts that have covered the stock in the last year is $58.33.

  • [By Logan Wallace]

    TRADEMARK VIOLATION NOTICE: “Brokerages Expect Abaxis (ABAX) Will Post Earnings of $0.32 Per Share” was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at www.tickerreport.com/banking-finance/3373644/brokerages-expect-abaxis-abax-will-post-earnings-of-0-32-per-share.html.

Best Blue Chip Stocks To Invest In 2019

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; font: 13.0px Verdana; -webkit-text-stroke: #000000} span.s1 {font-kerning: none}

Dow 19,000 has a nice ring to it. And the iconic blue chip stock gauge is edging ever closer to that milestone.

After Mondays record-breaking day, when the Dow Jones industrial average, large-company Standard & Poors 500 stock index, tech-dominated Nasdaq composite and the small-cap Russell 2000 all closed at record levels at the same time for the first time since Dec. 31, 1999, the Dow is on the verge of making more headlines and getting a big shout outon the evening news.

.oembed-asset-link { border-bottom: 1px solid #e1e1e1; } .oembed-link-anchor { display: block; clear: both; } .oembed-link-thumbnail{ float: left; padding: 14px; } .oembed-link-thumbnail img { max-width: 78px; max-height: 60px; display: block; } p.oembed-link-title { font-size: 75%; color: #009BFF; margin: 0 14px; padding-top: 12px; font-weight:normal; text-align: left; line-height: 120%; } p.oembed-link-desc { font-size: 100%; color: #666; font-weight: normal; margin: 0 14px 14px 14px; font-family: ‘Futura Today Light’; text-align: left; line-height: 120%; }

USA TODAY

Best Blue Chip Stocks To Invest In 2019: Kinross Gold Corporation(KGC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Kinross Gold Corporation (USA) (NYSE: KGC) is projected to post a quarterly loss at $0.01 per share on revenue of $808.09 million.

    Crocs, Inc. (NASDAQ: CROX) is expected to report its quarterly earnings at $0.05 per share on revenue of $265.90 million.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Kinross Gold Corporation (USA) (NYSE: KGC) and Yamana Gold Inc. (USA) (NYSE: AUY).

  • [By Lee Jackson]

    Kinross Gold Corp. (NYSE: KGC) may be the stock that give investors the most amount of leverage on a gold rebound. Management reduced the company’s annual capital expenditures forecast to $1.45 billion from $1.6 billion, saving $180 million from its cost restructuring initiatives. Cancellation of its upcoming semiannual dividend payment to its shareholders will save $182 million per year. Kinross expects to produce gold at a cost of $1,000 to $1,200 an ounce this year. The Merrill Lynch target is $7.00, and the consensus target is $6.55. The dividend, which soon will be cancelled, has a yield of 2.9%.

  • [By Wayne Duggan]

    Citi also placed Neutral ratings on Goldcorp Inc. (USA) (NYSE: GG), Kinross Gold Corporation (USA) (NYSE: KGC) and Silver Standard Resources Inc. (USA) (NASDAQ: SSRI).

  • [By Matthew DiLallo]

    Another major long-term project is Norte Abierto, which is also a 50/50 JV in Chile — this time with Barrick Gold — on one of the largest gold-copper discoveries in South America. Goldcorp just brought this project into its portfolio in 2017 after buying outKinross Gold’s (NYSE:KGC) 25% stake as well as a 25% interest from Barrick Gold.

Best Blue Chip Stocks To Invest In 2019: Durect Corporation(DRRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

  • [By Stephan Byrd]

    Algert Global LLC lifted its stake in Durect Co. (NASDAQ:DRRX) by 338.9% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 498,711 shares of the specialty pharmaceutical company’s stock after acquiring an additional 385,088 shares during the quarter. Algert Global LLC’s holdings in Durect were worth $1,067,000 as of its most recent SEC filing.

Best Blue Chip Stocks To Invest In 2019: MicroStrategy Incorporated(MSTR)

Advisors’ Opinion:

  • [By Chris Neiger]

    MicroStrategy (NASDAQ:MSTR) reported its first-quarter results on April 27, and the company saw its total revenue tick up by 1.3% year over year. Just as with the company’s fourth-quarter results, MicroStrategy’s management said foreign-currency headwinds continued to have a negative impact on the company’s overall sales.

  • [By Jim Robertson]

    Small cap Alarm.com Holdings would bethe leading platform for the intelligently connected property. Millions of people depend on Alarm.com Holdings technology to monitor and control their property from anywhere. Centered on security and remote monitoring, the Companys platform addresses a wide range of market needs and enables application-based control for a growing variety of Internet of Things (IoT) devices.Its security, video monitoring, intelligent automation and energy management solutions are available througha network of thousands of professional service providers in North America and around the globe. The Company went public in June 2015 as a spinoff from MicroStrategy Incorporated (NASDAQ: MSTR) with shares selling for $14 during the IPO.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on MicroStrategy (MSTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Blue Chip Stocks To Invest In 2019: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) dropped about 44% Friday to post a new 52-week low of $0.24 after closing at $0.43 on Thursday. Volume was around 12.5 million, about 20 times the daily average of around 650,000. The firm this morning priced an offering of 15 million shares and warrants to purchase up to another 15 million shares at $0.30 per unit.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 42 percent to $0.25. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) was down, falling around 40 percent to $0.26. Trovagene priced its 15 million share common stock offering at $0.30 per share.

  • [By Lisa Levin]

    TrovaGene Inc (NASDAQ: TROV) shares dropped 27 percent to $1.27. Trovagene reported a Q4 loss of $8.5 million on revenue of $68,000. Piper Jaffray downgraded TrovaGene from Neutral to Underweight.

  • [By Lisa Levin]

    Shares of TrovaGene Inc (NASDAQ: TROV) were down 13 percent to $5.28. Trovagene reported a Q4 loss of $(0.26) per share.

    Sunrun Inc (NASDAQ: RUN) was down, falling around 13 percent to $6.22. Sunrun reported a Q4 loss of $(0.15) per share on revenue of $99.6 million.

Best Medical Stocks To Watch For 2018

Chairman & CEO of Medtronic Plc (NYSE:MDT) Omar Ishrak sold 140,407 shares of MDT on 09/15/2017 at an average price of $81.63 a share. The total sale was $11.5 million.

Medtronic PLC is a medical technology company. It primarily manufacture and sell device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments. Medtronic PLC has a market cap of $111.62 billion; its shares were traded at around $82.40 with a P/E ratio of 27.74 and P/S ratio of 3.81. The dividend yield of Medtronic PLC stocks is 2.14%. Medtronic PLC had annual average EBITDA growth of 6.20% over the past ten years. GuruFocus rated Medtronic PLC the business predictability rank of 4.5-star.

CEO Recent Trades:

Chairman & CEO Omar Ishrak sold 140,407 shares of MDT stock on 09/15/2017 at the average price of $81.63. The price of the stock has increased by 0.94% since.

For the complete insider trading history of MDT, click here

Best Medical Stocks To Watch For 2018: PPL Corporation(PPL)

Advisors’ Opinion:

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $31.53 after closing Tuesday at $32.42. The 52-week high is $40.20. Volume was about 15.5 million, more than three times the daily average of around 4 million shares. The electric utility company took a downgrade on Tuesday and the fallout continues to drop.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $30.81 after closing Friday at $31.13. The 52-week high is $40.20. Volume was about 3.5 million, about 25% below the daily average of around 4.5 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $31.11 after closing Wednesday at $31.59. The 52-week high is $40.20. Volume was about 9.6 million, more than double the daily average of around 4.2 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $32.48 after closing Monday at $33.97. The 52-week high is $40.20. Volume was about 5.9 million, nearly a third higher than the daily average of around 3.9 million shares. The electric utility company had no specific news.

Best Medical Stocks To Watch For 2018: Armada Hoffler Properties, Inc.(AHH)

Advisors’ Opinion:

  • [By Lee Jackson]

    Armada Hoffler Properties Inc. (NYSE: AHH) is a vertically integrated, self-managed REIT developing, building, acquiring and managing high-quality, institutional-grade office, retail and multifamily properties. Investors receive a 5.78% yield. The shares have traded in a 52-week range of $12.66 to $16.01 and were recently seen at $13.85. The consensus price target is set at $15.17.

Best Medical Stocks To Watch For 2018: H&E Equipment Services Inc.(HEES)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of United Rentalsgiving a similar performance but alsopulling away fromsmall cap peer H&E Equipment Services, Inc (NASDAQ: HEES):

  • [By Peter Graham]

    A long term performance chart shows shares of United Rentalsgiving a similar performance and pulling away fromsmall cap peer H&E Equipment Services, Inc (NASDAQ: HEES):

Best Medical Stocks To Watch For 2018: Lithium X Energy Corp. (LIXXF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

  • [By Tom Bishop]

    Lithium X Energy NPV (LIXXF) owns 50% of the Sal de los Angeles lithium brine project in the prolific “Lithium Triangle” in mining friendly Salta province, Argentina.

Best Medical Stocks To Watch For 2018: L.B. Foster Company(FSTR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lee Jackson]

    The L.B. Foster Co. (NASDAQ: FSTR) had one of itsdirectors adding to a position last week. Legion Partners bought 72,301 shares of the transportation and energy infrastructure company at prices between $12.27 and $13.07. The total for the purchase came in right at $1 million. The shares closed Friday at $13.30, in a 52-week range of$9.25 to $20.77. The consensus price target is $15.00.

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

Best Medical Stocks To Watch For 2018: Durect Corporation(DRRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.